Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

The excitement around the new weight-loss industry is overtaking other disease areas and portfolios for publicly traded ...

The best online providers offer strong support services to help you succeed in your GLP-1 weight loss journey.

Novo Nordisk said Monday it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market where it estimates more than 180 million people live with obesity.

Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...

The chart below compares the forward price to earnings (P/E) ratio of AstraZeneca to multiples in a peer set of leading ...

Novo Nordisk and Eli Lilly are facing scores of personal injury claims for allegedly failing to warn patients about side ...

Eli Lilly (NYSE: LLY) sells a broad range of pharmaceuticals treating various diseases, but one portfolio in particular has ...